eli lilly phase 3 trial retatrutide Today, we shared new data from the latest study of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more Starting Phase 3b Clinical Trial

Right now, tirzepatide is considered one of the most powerful widely used medications for weight loss because of the significant body weight reductions seen in studies

Not losing weight on GLP-1s: Common pitfalls and fixes

Semaglutide at current pricing costs roughly $350-400 CAD per pound

A Conceptual Model of Food Cue Reactivity - PMC - PubMed Central, accessed April 22, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 22, 2025, GLP-1 and the Neurobiology of Eating Control: Recent Advances - Oxford Academic, accessed April 22, 2025, pmc.ncbi.nlm.nih.gov, accessed April 22, 2025, Taking a GLP-1

Side effects were most likely to show up when starting the medication or increasing the dose , which is why the step-up dosing schedule matters

A Metagenome-Wide Association Study of Gut Microbiota in Type 2 Diabetes